How Piramal Pharma is shaping resilient, patient-centric development across OSDs, HPAPIs, and sterile injectables.

A Bay Area biotech company is on the cusp of a potential breakthrough in blood cancer treatment, with regulators set to make ...

Could expensive drugs like Ozempic save healthcare systems money by reducing the risk of obesity-associated diseases? A new ...

AI, omics, and systems biology can now help scientists design targeted drugs for cardiovascular disease pathways once thought ...

Nerandomilast is the first FDA-approved treatment for IPF in over a decade, targeting lung function decline. The FDA has ...

Data from the HARMONi trial suggest that outcomes may differ between patients in China and those in North America or Europe.

Aerospace firm ORKID has introduced a new variant of its ORKID 260 drone. According to a press release from ORKID, the ORKID ...